Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients

Clinical Transplantation

Volumn 26, Issue 4, 2012, Pages

  Lim, Wai H ^a,b   Chadban, Steve J ^b,c   Clayton, Philip ^b   Budgeon, Charley A ^d   Murray, Kevin ^d   Campbell, Scott B ^b,e   Cohney, Solomon ^b,f   Russ, Graeme R ^b,g   Mcdonald, Stephen P ^b,g  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b ANZDATA Registry   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

ANZDATA registry; Graft survival; Human leukocyte antigen; Kidney transplant; Rejection

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; EVEROLIMUS; HLA AB ANTIGEN; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PREDNISOLONE; PROLIFERATION SIGNAL INHIBITOR; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CADAVER DONOR; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG POTENCY; GRAFT FAILURE; GRAFT RECIPIENT; HLA MATCHING; HLA MISMATCH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK FACTOR; SURVIVAL RATE;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84864933949     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01654.x     Document Type: Article

References (17)

1. Wissing K, Fomegné G, Broeders N et al. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies. Transplantation 2008: 85: 411.
2. Beckingham I, Dennis M, Bishop M, Blamey R, Smith S, Nicholson M. Effect of human leucocyte antigen matching on the incidence of acute rejection in renal transplantation. Br J Surg 1994: 81: 574.
3. Held P, Kahan B, Hunsicker L et al. The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med 1994: 331: 765.
4. McKenna R, Lee K, Gough J et al. Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function. Transplantation 1998: 66: 38.
5. Koyama H, Cecka J. Rejection episodes. Clin Transpl 1992: 391.
6. Opelz G, Dohler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007: 84: 137.
7. Gjertson D, Terasaki P, Takemoto S, Mickey M. National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med 1991: 324: 1032.
8. Takemoto S, Terasaki P, Gjertson D, Cecka J. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000: 343: 1078.
9. Schnitzler M, Hollenbeak C, Cohen D et al. The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med 1999: 341: 1440.
10. Gillich M, Heimbach D, Schoeneich G, Müller S, Klehr H. Comparison of blood group versus HLA-dependent transplantation and its influence on donor kidney survival. Nephrol Dial Transplant 2002: 17: 884.
11. Su X, Zenios S, Chakkera H, Milford E, Chertow G. Diminishing significance of HLA matching in kidney transplantation. Am J Transplant 2004: 4: 1501.
12. Opelz G, Dohler B. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. Transplantation 2009: 87: 795.
13. Roberts J, Wolfe R, Bragg-Gresham J et al. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med 2004: 350: 545.
14. Doxiadis I, de Fijter J, Mallat M et al. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation 2007: 83: 1207.
15. Vereerstraeten P, Abramowicz D, Andrien M, Dupont E, De Pauw L, Kinnaert P. Allocation of cadaver kidneys according to HLA-DR matching alone would result in optimal graft outcome in most recipients. Transplant Proc 1999: 31: 739.
16. Gilbert M, Paul S, Perrat G et al. Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome. Transplant Proc 2011: 43: 3412.
17. Terasaki P, Lachmann N, Cai J. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure. Clin Transpl 2006: 455.